Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
2016
ESUR prostate MR guidelines 2012
2012 Standout
Nasopharyngeal carcinoma
2005 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Prognostic Factors in Non-small Cell Lung Cancer
2002
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
1991
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Thymoma: Histologic subclassification is an independent prognostic factor
1994
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER
1999
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
2002 Standout
Recent results of management of palpable clinically localized prostate cancer
1993
Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature
1995
Pulmonary Toxicity Associated With the Treatment of Non-Small Cell Lung Cancer and the Effects of Cytoprotective Strategies
2005
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
1999
Reported management of lung cancer in Victoria in 1993: comparison with best practice
2000
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
2001
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588
1997
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
2000
Lung Cancer
2008 Standout
Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies
2002
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 Standout
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
2003
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Imaging of prostate cancer local recurrences: why and how?
2009
Accelerated Hyperfractionation in Patients with Non-Small Cell Bronchogenic Cancers as a Cost-Effective and User- and Patient-Friendly Schedule
2000
Treatment of head and neck cancer: the role of chemotherapy
1996
Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?
1999
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
1997
Conformity index: A review
2006 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Ten-year survey of lung cancer treatment and survival in hospitals in the United States
1999
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
2008
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas
2002
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study
1997
Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone
1992
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach
2001
Management of head and neck cancer
1994
The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non–small cell lung cancer
2002
Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors
2002
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer
2001
EAU Guidelines on Prostate Cancer
2007 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Adjuvant chemotherapy in head and neck cancer
1990
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan
2003 Standout
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
1998
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
2000
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
1996
Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer
2000
Head and Neck Cancer
1993 Standout
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
2009
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
1999
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy
2004
A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
2005
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
2003
A Phase III Randomized Trial of Combined Chemoradiotherapy Versus Radiotherapy Alone in Locally Advanced Non–Small-Cell Lung Cancer
2002
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
1997
PEGylation, successful approach to drug delivery
2005 Standout
Prostate-specific antigen and radiation therapy for clinically localized prostate cancer
1995
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Revisions in the International System for Staging Lung Cancer
1997 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
2004
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer
2002
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
2002
Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck
1990
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
2011
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
2001
Anemia of Chronic Disease
2005 Standout
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck
1994
Head and Neck Cancer
2020 Standout
Nonsurgical management of malignant thymoma
1999
Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer
2000
Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck Cancer
1999
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
1999
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma
2001
Decision aids for people facing health treatment or screening decisions
2017 Standout
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
1999
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
1997
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal Therapy Consortium
2001
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
1999
Randomized Trials of Induction Chemotherapy: A Critical Review
1991
The role of radiotherapy in cancer treatment
2005 Standout
Adjuvant chemotherapy in head and neck cancer
1992
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
1998
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
1999
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
2004
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Phase I Study of a Decision Aid for Patients With Locally Advanced Non–Small-Cell Lung Cancer
2001
Adjuvant Chemotherapy in Head and Neck Cancer.
1992
Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
1998
Consensus statement: Guidelines for PSA following radiation therapy1
1997 Standout
Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
2001
Works of J.D. Cox being referenced
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The radiation therapy oncology group 75-06 and 77-06 experience
1991
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
1995
Thymoma: Treatment and prognosis
1992
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433
1993
NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
1996
Phase III trial of hormonal cytoreduction in conjunction with definitive radiotherapy in locally advanced prostate carcinoma: the emerging role of psa in the assessment of outcome
1993
The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer.
1983
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)
1992
Cisplatin and Fluorouracil as Neoadjuvant Therapy in Head and Neck Cancer: A Preliminary Report
1987